During the past decade, Oncology Center Sf. Nectarie conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 28 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 20 clinical trials were completed. i.e. 87% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Center Sf. Nectarie" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Center Sf. Nectarie" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Center Sf. Nectarie" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Gastric Cancer" (3 trials) and "Triple-Negative Breast Cancer" (3 trials). Many other conditions were trialed in "Oncology Center Sf. Nectarie" in a lesser frequency.

Most popular intervention types in "Oncology Center Sf. Nectarie" are "Drug" (59 trials), "Biological" (13 trials), "Other" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Paclitaxel" (15 trials), "Carboplatin" (12 trials), "Cisplatin" (11 trials) and "Atezolizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Center Sf. Nectarie" are 57 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Center Sf. Nectarie". undefined are not yet recruiting, 16 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Oncology Center Sf. Nectarie, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Center Sf. Nectarie, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".